BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15975260)

  • 1. Characterisation of protein microheterogeneity and protein complexes using on-chip immunoaffinity purification-mass spectrometry.
    Schweigert FJ
    Brief Funct Genomic Proteomic; 2005 May; 4(1):7-15. PubMed ID: 15975260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
    Zanotti G; Berni R
    Vitam Horm; 2004; 69():271-95. PubMed ID: 15196886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
    Raghu P; Sivakumar B
    Biochim Biophys Acta; 2004 Dec; 1703(1):1-9. PubMed ID: 15588697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of in vivo assembled multiprotein complexes via biomolecular interaction analysis mass spectrometry.
    Nedelkov D; Nelson RW
    Proteomics; 2001 Nov; 1(11):1441-6. PubMed ID: 11922603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for purification of human plasma retinol-binding protein and transthyretin.
    Raghu P; Ravinder P; Sivakumar B
    Biotechnol Appl Biochem; 2003 Aug; 38(Pt 1):19-24. PubMed ID: 12593674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP.
    Naylor HM; Newcomer ME
    Biochemistry; 1999 Mar; 38(9):2647-53. PubMed ID: 10052934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of transthyretin and retinol-binding protein in plasma and cerebrospinal fluid of dogs.
    Forterre S; Raila J; Forterre F; Brunnberg L; Schweigert FJ
    Vet J; 2006 May; 171(3):451-5. PubMed ID: 16624711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
    Saraiva MJ; Costa PP; Goodman DS
    J Lab Clin Med; 1983 Oct; 102(4):590-603. PubMed ID: 6311926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex.
    Hyung SJ; Deroo S; Robinson CV
    ACS Chem Biol; 2010 Dec; 5(12):1137-46. PubMed ID: 20845945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput protein characterization using mass spectrometric immunoassay.
    Kiernan UA; Tubbs KA; Gruber K; Nedelkov D; Niederkofler EE; Williams P; Nelson RW
    Anal Biochem; 2002 Feb; 301(1):49-56. PubMed ID: 11811966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.
    Kiernan UA
    Expert Rev Proteomics; 2007 Jun; 4(3):421-8. PubMed ID: 17552926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies on human retinol-binding protein using site-directed mutagenesis.
    Sivaprasadarao A; Findlay JB
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):437-42. PubMed ID: 8002949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modifications of serum transthyretin in rats during protein-energy malnutrition.
    Henze A; Rohn S; Gericke B; Raila J; Schweigert FJ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3270-4. PubMed ID: 18819112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of transthyretin (TTR) and retinol-binding protein (RBP) in the uptake of retinol by primary rat hepatocytes.
    Yamamoto Y; Yoshizawa T; Kamio S; Aoki O; Kawamata Y; Masushige S; Kato S
    Exp Cell Res; 1997 Aug; 234(2):373-8. PubMed ID: 9260907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical basis for retinol deficiency induced by the I41N and G75D mutations in human plasma retinol-binding protein.
    Folli C; Viglione S; Busconi M; Berni R
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1017-22. PubMed ID: 16157297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.
    Trenchevska O; Kamcheva E; Nedelkov D
    Proteomics; 2011 Sep; 11(18):3633-41. PubMed ID: 21751365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structure of the transthyretin-retinol-binding protein complex.
    Monaco HL
    Clin Chem Lab Med; 2002 Dec; 40(12):1229-36. PubMed ID: 12553423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.
    Chen L; Collins XH; Tabatabai LB; White WS
    Lipids; 2005 Oct; 40(10):1013-22. PubMed ID: 16382573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between retinol-binding protein and transthyretin analyzed by fluorescence anisotropy.
    Folli C; Favilla R; Berni R
    Methods Mol Biol; 2010; 652():189-207. PubMed ID: 20552430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of retinol-binding protein-transthyretin interaction and techniques to identify competing ligands.
    Mata NL; Phan K; Han Y
    Methods Mol Biol; 2010; 652():209-27. PubMed ID: 20552431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.